Latest Publishing News

Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial stays on track for November topline results, buoyed by strong open-label extension enrolment and aligned EMA-FDA regulatory advice. A new antidepressant study publication and fresh patents add momentum, supported by a $16.7 million cash runway to mid-2027.

Barton Gold has delivered another batch of strong assay results from its Phase 2 drilling at the Tunkillia Gold Project, reinforcing the economic potential of Area 223 and advancing its Pre-Feasibility Study towards a Q1 2027 finish.

Streamplay Studio Limited has reported its fifth straight quarter of positive operating cash flow, driven by strong customer receipts and strategic publishing deals. The company is advancing multiple game releases and expanding its cloud gaming footprint across new regions.

Nickel Industries delivered a record US$45.7 million Adjusted EBITDA from its Hengjaya Mine, launched first mixed hydroxide precipitate production at its ENC HPAL project, and secured major HPAL asset acquisitions, positioning itself for growth across the nickel value chain.

KALiNA Power has strengthened its foothold in Alberta’s booming AI data centre sector, securing a C$18 million load sale to Meta alongside key regulatory reforms that enhance project flexibility and commercial prospects.

Amplia Therapeutics reported encouraging mature data from its ACCENT trial, initiated a Phase 2b pancreatic cancer study, launched an ovarian cancer trial, and refreshed its board leadership while maintaining a solid cash balance of A$24 million.

Green Technology Metals (ASX: GT1) completed an A$11 million recapitalisation, advancing its Seymour Lithium Project DFS, permitting, and financing efforts with a target Final Investment Decision in 2027.

Clinuvel Pharmaceuticals targets year-end for topline results from its pivotal vitiligo trial of SCENESSE® combined with narrowband UVB, aiming to expand the drug's use beyond its current rare disease indication.

Barton Gold’s June quarter report highlights exceptional high-grade gold and silver assay results across its South Australian projects, backed by a $26 million institutional placement that strengthens its cash position and development outlook.

Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.

Meteoric Resources has significantly boosted its Caldeira Rare Earth Project with a 246% increase in Measured Resources and pilot plant recoveries surpassing pre-feasibility targets, backed by a $40 million capital raise and advancing environmental approvals.

Newmont delivered solid second quarter 2026 results, generating $2.2 billion net income and record $2.2 billion free cash flow despite production setbacks at Cadia. The gold miner remains on track to meet full-year guidance while returning $1.9 billion to shareholders through dividends and buybacks.